Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

Projects work toward the development of novel drug and cell therapy for the treatment of demyelinating diseases such as Multiple Sclerosis (MS) and myelin diseases of children such as leukodystrophies ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis ... the role played in the disease by B cells, another type of white blood ...

Tolebrutinib did not show superiority over Aubagio (teriflunomide) in reducing relapse rates or MRI-detected inflammatory ...

The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...

By studying the effects of the nasal anti-CD3 in a ... Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped ...

Early treatment with Ocrevus may help protect the cerebellum from damage in people with multiple sclerosis, a study found.

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple ... white blood cells known as T cells were the lone culprit. Hauser questioned that. Studying ...